Guardant Health
GH
#1935
Rank
NZ$18.08 B
Marketcap
NZ$137.88
Share price
-3.26%
Change (1 day)
70.57%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

We have found no dividend yield history for this company